Qilu Hospital of Shandong University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Neoadjuvant Immunotherapy for Resectable Gastric Cancer
Phase 2
Completed
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 25
- Registration Number
- NCT03878472
- Locations
- 🇨🇳
Qilu hospital of Shandong univertisy, Jinan, Shandong, China
The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment
Phase 4
Completed
- Conditions
- Arthritis, Rheumatoid
- Interventions
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 400
- Registration Number
- NCT03855007
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients
- Conditions
- Type 2 Diabetes MellitusPoor Glycemic Control
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 900
- Registration Number
- NCT03805191
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, China
A Validation Study of The Relationship Between ALDH2 and Aortic Dissection
- Conditions
- Aortic Dissection
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT03780738
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guanzhou, Guangdong, China
Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
Phase 2
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2018-11-26
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 46
- Registration Number
- NCT03750916
Evaluate the Impact of Arm Abduction and Adduction on the Intravascular Electrocardiograph During PICC Placement and the Tip Location Changes Related to it
Not Applicable
- Conditions
- Catheterization, PeripheralCatheterization, Central Venous
- Interventions
- Procedure: arm abduction and adduction
- First Posted Date
- 2018-07-19
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 150
- Registration Number
- NCT03592602
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Evaluation of Antithrombotic STrategies in STEMI Patients in China
- Conditions
- Emergent PCISTEMI
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 8000
- Registration Number
- NCT03510832
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
Phase 4
- Conditions
- NSTEMI - Non-ST Segment Elevation MIEarly ManagementAcute Heart Failure
- Interventions
- Drug: Regular management+Levosimendan
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 470
- Registration Number
- NCT03189901
- Locations
- 🇨🇳
Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
🇨🇳Binzhou People's Hospital, Binzhou, Shandong, China
Bone Metastasis on the Survival of Gefitinib Effective Patients
Not Applicable
Completed
- Conditions
- Overal Survival, Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2017-05-17
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 265
- Registration Number
- NCT03157310
Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)
Phase 2
- Conditions
- Advanced Nsclc
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2019-06-05
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 232
- Registration Number
- NCT03062800
- Locations
- 🇨🇳
Qilu hospital of Shandong University, Jinan, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath